NanoViricides
NNVC
#10132
Rank
NZ$38.31 M
Marketcap
NZ$2.13
Share price
0.82%
Change (1 day)
-14.22%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2025 : NZ$13.01 Million

According to NanoViricides's latest financial reports the company has NZ$13.01 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$NZ$18.79 M-22.45%
2023-06-30$NZ$24.23 M-34.48%
2022-06-30$NZ$36.98 M-13.48%
2021-06-30$NZ$42.75 M26.75%
2020-06-30$NZ$33.72 M113.91%
2019-06-30$NZ$15.76 M-39.55%
2018-06-30$NZ$26.08 M-6.03%
2017-06-30$NZ$27.75 M-14.06%
2016-06-30$NZ$32.29 M-31.04%
2015-06-30$NZ$46.83 M75.61%
2014-06-30$NZ$26.66 M157.63%
2013-06-30$NZ$10.35 M-40.02%
2012-06-30$NZ$17.25 M40.56%
2011-06-30$NZ$12.27 M30.29%
2010-06-30$NZ$9.42 M143.08%
2009-06-30$NZ$3.87 M564.68%
2008-06-30$NZ$0.58 M-10.38%
2007-06-30$NZ$0.65 M-68.17%
2006-06-30$NZ$2.04 M-2219.02%
2005-06-30$-NZ$0.1 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion-5,259.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.28 Billion-2,184.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.14 B 285,311.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 247,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.85 B 690,375.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.65 B 281,586.77%๐Ÿ‡ฌ๐Ÿ‡ง UK